Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.

Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Eli Lilly receives CDSCO approval for donanemab, a new Alzheimer's treatment targeting early symptomatic stages of the ...

Alzheimer’s disease impacts tens of millions of families throughout the world, and projections state that more than 100 ...

Investing.com -- Eli Lilly and Company (India) Pvt. has received marketing approval from India’s Central Drugs Standard Control Organization for donanemab, a medication used to treat Alzheimer’s ...

Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...

A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. Two other medicines, to treat erectile dysfunction and motor neurone disease, also showed strong potential.

Scientists tested the substance on rats with positive results and are now seeking partnerships with pharmaceutical companies to conduct clinical trials. A research team at the Federal University of AB ...